Arachidonic acid inhibits Na +-K +-ATPase via cytochrome P-450, lipoxygenase and protein kinase C-dependent pathways in sheep pulmonary artery

Vascular Pharmacology

Volumn 56, Issue 1-2, 2012, Pages 84-90

  Singh, Thakur Uttam ^a   Choudhury, Soumen ^a   Parida, Subhashree ^a   Maruti, Bhojane Somnath ^a   Mishra, Santosh Kumar ^a  

^a INDIAN VETERINARY RESEARCH INSTITUTE   (India)

Author keywords

Arachidonic acid; Na + K + ATPase; Pulmonary artery; Sheep

Indexed keywords

17 OCTADECYNOIC ACID; 20 HYDROXYICOSATETRAENOIC ACID; ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ARACHIDONIC ACID; CYTOCHROME P450; CYTOCHROME P450 INHIBITOR; HET 0016; INDOMETACIN; LIPOXYGENASE; NORHYDIHYDROGUAIARETIC ACID; POTASSIUM CHLORIDE; PROTEIN KINASE C; SEROTONIN; STAUROSPORINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERY TONE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; LUNG BLOOD VESSEL; MALE; NONHUMAN; PRIORITY JOURNAL; PULMONARY ARTERY; SHEEP;

ANIMALS; ARACHIDONIC ACID; CYTOCHROME P-450 ENZYME SYSTEM; FATTY ACIDS, UNSATURATED; HYDROXYEICOSATETRAENOIC ACIDS; INDOMETHACIN; LIPOXYGENASE; LUNG; MALE; POTASSIUM; POTASSIUM CHLORIDE; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; PROTEIN KINASE C; PULMONARY ARTERY; SEROTONIN; SHEEP; SIGNAL TRANSDUCTION; SODIUM-POTASSIUM-EXCHANGING ATPASE; STAUROSPORINE; VASODILATION;

EID: 84856295476     PISSN: 15371891     EISSN: 18793649     Source Type: Journal    
DOI: 10.1016/j.vph.2011.11.005     Document Type: Article

References (39)

1. +-ATPase by arachidonic and linoleic acid. Naunyn Schmiedebergs Arch. Pharmacol. 1986, 332(4):398-402.
2. 2+ stores and cell responsiveness. Am. J. Physiol. 1993, 264:C1367-C1387.
3. Blobe G.C., Khan W.A., Hannun Y.A. Protein kinase C: cellular target of the second messenger arachidonic acid. Prostaglandins Leukot. Essent. Fatty. Acids 1995, 52(2-3):129-135.
4. +-ATPase activity due to fatty acids and acute hypertension. Brain Res. 1993, 602(2):215-220.
5. +-ATPase in the regulation of basal tone and agonist-induced contractility in ovine pulmonary artery. J. Cardiovasc. Pharmacol. 2008, 52:167-175.
6. Chen S.G., Murakami K. Synergistic activation of type III protein kinase C by cis-fatty acid and diacylglycerol. Biochem. J. 1992, 282:33-39.
7. V1.5 channel expression through endogenous 15-HETE in rat pulmonary artery. Prostaglandins Lipid Mediat. 2009, 88(1-2):42-50.
8. + channels and pulmonary vasoconstriction: role of protein kinase Czeta. Circ. Res. 2003, 93(7):656-663.
9. +-pump in smooth muscle: physiologic and pharmacologic significance. Ann. Rev. Pharmacol. Toxicol. 1980, 20:129-149.
10. Fuloria M., Eckman D.M., Leach D.A., Aschner J.L. 20-hydroxyeicosatetraenoic acid is a vasoconstrictor in the newborn piglet pulmonary microcirculation. Am. J. Phys. Lung Cell. Mol. Physiol. 2004, 287(2):L360-L365.
11. Haag M., Kearns S.D., Magada O.N., Mphata P.R., Claassen N., Kruger M.C. Effect of arachidonic acid on duodenal enterocyte ATPases. Prostaglandins Lipid Mediat. 2001, 66(1):53-63.
12. +-ATPase inhibitor constricts pulmonary arteries of spontaneously hypertensive rats. J. Cardiovasc. Pharmacol. 1993, 22:S42-S46.
13. Kehl F., Cambj-Sapunar L., Maier K.G., Miyata N., Kametani S., Okamoto H., Hudetz A.G., Schulte M.L., Zagorac D., Harder D.R., Roman R.J. 20-HETE contributes to the acute fall in cerebral blood flow after subarachnoid hemorrhage in the rat. Am. J. Physiol. Heart Circ. Physiol. 2002, 282:H1556-H1565.
14. +-ATPase are age dependent. Am. J. Physiol. Renal Physiol. 2000, 278(5):F823-F829.
15. Lin F., Abraham N.G., Schwartzman M.L. Cytochrome P450 arachidonic acid omega-hydroxylation in the proximal tubule of the rat kidney. Ann. N. Y. Acad. Sci. 1994, 744:11-24.
16. Marin J., Redondo J. Vascular sodium pump: endothelial modulation and alterations in some pathological processes and aging. Pharmacol. Ther. 1999, 84(3):249-271.
17. Miyata N., Taniguchi K., Seki T., Ishimoto T., Sato-Watanabe M., Yasuda Y., Doi M., Kametani S., Tomishima Y., Ueki T., Sato M., Kameo K. HET0016, a potent and selective inhibitor of 20-HETE synthesizing enzyme. Br. J. Pharmacol. 2001, 133:325-329.
18. Nishizuka Y. Protein kinase C and lipid signaling for sustained cellular responses. FASEB J. 1995, 9(7):484-496.
19. +-ATPase. J. Clin. Invest. 1997, 99(6):1224-1230.
20. O'Donnell M.E., Owen N.E. Regulation of ion pumps and carriers in vascular smooth muscle. Physiol. Rev. 1994, 74:683-721.
21. Omata K., Abraham N.G., Schwartzman M.L. Renal cytochrome P-450-arachidonic acid metabolism: localization and hormonal regulation in SHR. Am. J. Physiol. 1992, 262:F591-F599.
22. +-ATPase activity in the proximal tubule: role of the protein kinase C pathway and of eicosanoids. J. Membr. Biol. 1996, 152(3):235-243.
23. Park S.J., Yoo H.Y., Earm Y.E., Kim S.J., Kim J.K., Kim S.D. Role of arachidonic acid-derived metabolites in the control of pulmonary arterial pressure and hypoxic pulmonary vasoconstriction in rats. Br. J. Anaesth. 2011, 106(1):31-37.
24. Parker T.A., Grover T.R., Kinsella J.P., Falck J.R., Abman S.H. Inhibition of 20-HETE abolishes the myogenic response during NOS antagonism in the ovine fetal pulmonary circulation. Am. J. Physiol. Lung Cell. Mol. Physiol. 2005, 289(2):L261-L267.
25. Pfister S.L. Role of lipooxygenase metabolites of arachidonic acid in enhanced pulmonary artery contractions of female rabbits. Hypertens. 2011, 57(4):825-832.
26. +-ATPase through a cytochrome P-450 pathway. Am. J .Physiol. Renal Fluid. Electrolytes. Physiol. 1994, 266:F497-F505.
27. +-ATPase activity in the tail artery from L-NAME-treated rats. Life Sci. 2003, 74(5):613-627.
28. Sarkis A., Lopez B., Roman R.J. Role of 20-hydroxyeicosatetraenoic acid and epoxyeicosatrienoic acids in hypertension. Curr. Opin. Nephrol. Hypertens. 2004, 13(2):205-214.
29. + - ATPase. I. Role of cyclic AMP and phospholipase A2. J. Clin. Invest. 1992, 89(5):1496-1500.
30. Schwartzman M.L., Abraham N.G. The renal cytochrome P-450 arachidonic acid system. Pediatr. Nephrol. 1992, 6:490-498.
31. Sekiguchi K., Tsukuda M., Ogita K., Kikkawa U., Nishizuka Y. Three distinct forms of rat brain protein kinase C: differential response to unsaturated fatty acids. Biochem. Biophys. Res. Commun. 1987, 145(2):797-802.
32. Shinomura T., Asaoka Y., Oka M., Yoshida K., Nishizuka Y. Synergistic action of diacylglycerol and unsaturated fatty acid for protein kinase C activation: its possible implications. Proc. Natl. Acad. Sci. U. S. A. 1991, 88(12):5149-5153.
33. +-adenosine trisphosphatase activity of pulmonary arteries after intoxication with the pyrrolizine alkaloid, monocrotaline. J. Pharmacol. Exp. Ther. 1990, 252:70-76.
34. + current in rat pulmonary arterial myocytes. Circ. Res. 1996, 79:20-31.
35. Snapper J.R., Lu W., Lefferts P.L., Thabes J.S. Cyclooxygenase products contribute to endothelin-induced pulmonary hypertension and altered lung mechanics in sheep. Pulm. Pharmacol. Ther. 1997, 10(2):111-118.
36. +-ATPase activity. Am. J. Physiol. Lung. Cell. Mol. Physiol. 1996, 271:L172-L177.
37. +-ATPase activity in vascular smooth muscle. Blood Vessels 1978, 15:198-207.
38. Zhao X., Imig J.D. Kidney CYP450 enzymes: biological actions beyond drug metabolism. Curr. Drug Metab. 2003, 4(1):73-84.
39. Zhu D., Birks E.K., Dawson C.A., Patel M., Falck J.R., Presberg K., Roman R.J., Jacobs E.R. Hypoxic pulmonary vasoconstriction is modified by P-450 metabolites. Am. J. Physiol. Heart Circ. Physiol. 2000, 279(4):H1526-H1533.